13 Dec SAHPRA’s position on Semaglutide compounded productsPosted at 14:43h in News & Updates, Press Releases by Melanie GovindasamyShare Pretoria, 13 December 2023 – The South African Health Products Regulatory…
22 Jul SAHPRA dismisses unfounded misinformation campaign deliberately misrepresenting its draft B-BBEE Policy by some sectors of society and media organisationsPosted at 11:53h in News & Updates, Press Releases by…
16 Sep SAHPRA attains clean audit outcome for the 2023/2024 financial yearPosted at 12:29h in News & Updates, Press Releases by Melanie GovindasamyShare Pretoria, 16 September 2024 –The South African…
07 Nov SAHPRA encourages the safe use of medicines and reporting of suspected side effects this #MedSafetyWeekPosted at 10:23h in News & Updates, Press Releases by Melanie GovindasamyShare Pretoria, 07…
08 Nov SAHPRA’s position on GLP1 and GIP-GLP1 products that are compounded, substandard and falsifiedPosted at 21:18h in News & Updates, Press Releases by Ntokozo MsizaShare Pretoria, 08 November 2024…
